rs1057517574
|
|
1.000 |
|
17 |
43090983 |
stop gained
|
G/A;T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1057517590
|
|
1.000 |
|
17 |
43063370 |
frameshift variant
|
A/-
|
del
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1057518636
|
|
1.000 |
|
17 |
43047646 |
frameshift variant
|
-/A
|
ins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1057518636
|
|
1.000 |
|
17 |
43047646 |
frameshift variant
|
-/A
|
ins
|
|
|
Mammary Neoplasms
|
0.700 |
|
0 |
|
|
rs1057518636
|
|
1.000 |
|
17 |
43047646 |
frameshift variant
|
-/A
|
ins
|
|
|
Neoplastic Syndromes, Hereditary
|
0.700 |
|
0 |
|
|
rs1057518639
|
|
0.925 |
0.200 |
17 |
43070951 |
missense variant
|
A/G
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1057518639
|
|
0.925 |
0.200 |
17 |
43070951 |
missense variant
|
A/G
|
snv
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1057519558
|
|
0.925 |
0.200 |
17 |
43082518 |
stop gained
|
C/A;G;T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1057519558
|
|
0.925 |
0.200 |
17 |
43082518 |
stop gained
|
C/A;G;T
|
snv
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502327
|
|
0.925 |
0.200 |
17 |
43099877 |
splice acceptor variant
|
C/-
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502327
|
|
0.925 |
0.200 |
17 |
43099877 |
splice acceptor variant
|
C/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502332
|
|
0.925 |
0.200 |
17 |
43093401 |
frameshift variant
|
A/TT
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502332
|
|
0.925 |
0.200 |
17 |
43093401 |
frameshift variant
|
A/TT
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502333
|
|
0.882 |
0.200 |
17 |
43093322 |
frameshift variant
|
T/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502333
|
|
0.882 |
0.200 |
17 |
43093322 |
frameshift variant
|
T/-
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502333
|
|
0.882 |
0.200 |
17 |
43093322 |
frameshift variant
|
T/-
|
delins
|
|
|
ovarian neoplasm
|
0.700 |
|
0 |
|
|
rs1060502334
|
|
0.925 |
0.200 |
17 |
43093258 |
stop gained
|
A/T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502334
|
|
0.925 |
0.200 |
17 |
43093258 |
stop gained
|
A/T
|
snv
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502345
|
|
0.925 |
0.200 |
17 |
43091465 |
frameshift variant
|
GAT/A
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502345
|
|
0.925 |
0.200 |
17 |
43091465 |
frameshift variant
|
GAT/A
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502354
|
|
0.925 |
0.200 |
17 |
43093214 |
frameshift variant
|
GTACCAA/-
|
del
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502354
|
|
0.925 |
0.200 |
17 |
43093214 |
frameshift variant
|
GTACCAA/-
|
del
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502356
|
|
0.925 |
0.200 |
17 |
43057046 |
splice donor variant
|
ACCTTT/-
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1060502359
|
|
0.925 |
0.200 |
17 |
43094643 |
frameshift variant
|
GTCT/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 |
|
0 |
|
|
rs1060502360
|
|
0.925 |
0.200 |
17 |
43094787 |
frameshift variant
|
G/-
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|